- Home
- BDSX vs SGC Comparison
BDSX vs SGC Comparison
Compare BDSX & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- SGC
- Stock Information
- Founded
- BDSX 2005
- SGC 1920
- Country
- BDSX United States
- SGC United States
- Employees
- BDSX N/A
- SGC N/A
- Industry
- BDSX Precision Instruments
- SGC Apparel
- Sector
- BDSX Health Care
- SGC Consumer Discretionary
- Exchange
- BDSX Nasdaq
- SGC Nasdaq
- Market Cap
- BDSX 245.3M
- SGC 252.6M
- IPO Year
- BDSX 2020
- SGC N/A
- Fundamental
- Price
- BDSX $1.70
- SGC $15.12
- Analyst Decision
- BDSX Strong Buy
- SGC Strong Buy
- Analyst Count
- BDSX 4
- SGC 2
- Target Price
- BDSX $3.08
- SGC $22.00
- AVG Volume (30 Days)
- BDSX 243.1K
- SGC 78.3K
- Earning Date
- BDSX 11-05-2024
- SGC 11-04-2024
- Dividend Yield
- BDSX N/A
- SGC 3.74%
- EPS Growth
- BDSX N/A
- SGC N/A
- EPS
- BDSX N/A
- SGC 0.68
- Revenue
- BDSX $60,902,000.00
- SGC $553,945,000.00
- Revenue This Year
- BDSX $48.06
- SGC $4.89
- Revenue Next Year
- BDSX $29.97
- SGC $4.84
- P/E Ratio
- BDSX N/A
- SGC $22.21
- Revenue Growth
- BDSX 46.25
- SGC 1.22
- 52 Week Low
- BDSX $1.15
- SGC $7.40
- 52 Week High
- BDSX $2.21
- SGC $21.80
- Technical
- Relative Strength Index (RSI)
- BDSX 46.56
- SGC 51.96
- Support Level
- BDSX $1.62
- SGC $14.79
- Resistance Level
- BDSX $1.71
- SGC $15.28
- Average True Range (ATR)
- BDSX 0.06
- SGC 0.33
- MACD
- BDSX -0.00
- SGC 0.00
- Stochastic Oscillator
- BDSX 50.00
- SGC 49.47
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.